The Impact of Salsalate Treatment on Serum Levels of Advanced Glycation End Products in Type 2 Diabetes

OBJECTIVE: Salsalate is a nonacetylated salicylate that lowers glucose levels in people with type 2 diabetes (T2D). Here we examined whether salsalate also lowered serum-protein-bound levels of early and advanced glycation end products (AGEs) that have been implicated in diabetic vascular complicati...

Descripción completa

Detalles Bibliográficos
Autores principales: Barzilay, Joshua I., Jablonski, Kathleen A., Fonseca, Vivian, Shoelson, Steven E., Goldfine, Allison B., Strauch, Christopher, Monnier, Vincent M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2014
Materias:
Pathophysiology/Complications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964486/
https://www.ncbi.nlm.nih.gov/pubmed/24255104
http://dx.doi.org/10.2337/dc13-1527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964486/
https://www.ncbi.nlm.nih.gov/pubmed/24255104
http://dx.doi.org/10.2337/dc13-1527

Ejemplares similares